Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Active Ingredient Penetration Testing in Transdermal Patches

Posted on By

SOP for Active Ingredient Penetration Testing in Transdermal Patches

Standard Operating Procedure for Active Ingredient Penetration Testing in Transdermal Patches

1) Purpose

To establish procedures for testing the penetration of active ingredients through the skin in transdermal patches to ensure efficacy and compliance with product specifications.

2) Scope

This SOP applies to the quality control department responsible for conducting active ingredient penetration testing during transdermal patch manufacturing.

3) Responsibilities

3.1 Quality Control Analyst: Perform penetration testing according to defined procedures.
3.2 Production Supervisor: Provide samples for testing in accordance with sampling plans.
3.3 QA Personnel: Review and approve testing procedures and results.
3.4 Research and Development: Provide support in developing and validating penetration testing methods.

See also  SOP for Compatibility Testing of Transdermal Patches with Packaging Materials

4) Procedure

4.1 Sample Preparation:

4.1.1 Cut transdermal patches into appropriate sections or units for testing.

4.1.2 Ensure samples are identified with batch information and sampling details.

4.2 Testing Method:

4.2.1 Place transdermal patch samples on skin membrane models or suitable biological membranes.

4.2.2 Apply testing conditions such as temperature, humidity, and exposure time as per protocol.

4.3 Analysis of Penetration:

4.3.1 Collect samples after specified exposure periods and remove excess formulation.

4.3.2 Analyze

samples using validated analytical methods to quantify active ingredient penetration.

4.4 Data Interpretation:

4.4.1 Calculate penetration rates and compare against acceptance criteria or specifications.

See also  SOP for Continuous Improvement in Transdermal Patches Production

4.4.2 Record observations and deviations from expected results, if any.

4.5 Reporting:

4.5.1 Document testing procedures, results, and conclusions in designated test records or laboratory notebooks.

4.5.2 Prepare test reports summarizing penetration testing outcomes and compliance with specifications.

4.6 Documentation:

4.6.1 Maintain detailed records of penetration testing activities, including raw data and calculations.

4.6.2 Archive test reports and related documentation for review and audits as per document control procedures.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance
R&D: Research and Development

6) Documents, if any

Penetration Testing Protocols
Test Reports
Batch Production Records

7) Reference, if any

See also  SOP for Quality Control Testing of Transdermal Patches

USP General Chapter 1724: Performance Tests on Transdermal Drug Delivery Systems
ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Quality Control Testing of Granules
Next Post: SOP for Gel Packaging Machine

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version